Metal-based probes for detection of dopamine receptors, a cancer biomarker

May 15, 2018, Hong Kong Baptist University

A team at Hong Kong Baptist University has developed the world's first iridium(III)-based probes for imaging dopamine receptors in living cells. The discovery has enhanced the understanding of dopamine receptors in carcinogenesis, and the findings can be potentially developed as a novel early cancer detection technology.

A team led by Dr. Edmond Ma Dik-lung, Associate Professor of the Department of Chemistry of Hong Kong Baptist University (HKBU) has developed the world's first iridium(III)-based probes for imaging in living cells. The discovery has enhanced the understanding of receptors in carcinogenesis, and the findings can be potentially developed as a novel early detection technology. The study was published in the inside front cover of Chemical Science, the flagship journal of the Royal Society of Chemistry.

Dopamine is an important neurotransmitter in the central nervous system of the human body and plays important roles in motivation, cognition and motor control. While dopamine receptors have long been implicated in neurodegenerative diseases, such as Parkinson's disease, recent evidence has linked dopamine receptors also with various cancers, including lung, breast and colon cancers. Traditional detection methods for dopamine receptors include the enzyme-linked immunosorbent assay (ELISA). However, such methods suffer from high cost, incompatibility with living systems, and are not suitable for the real-time study of the biological role of dopamine receptors.

The metal-based probes developed by the team are able to selectively bind to dopamine receptors on lung cancer cells, "lighting up" the cells and making them visible to the naked eye. The probes enable the monitoring and tracking of dopamine receptors in living cells in a real-time and in a non-invasive fashion. Moreover, the experiment results demonstrated that the imaging colour intensity was correlates with the expression levels of dopamine receptors on cancer cells. These probes could therefore both help to elucidate the role of dopamine receptors in the pathogenesis of cancers and offer a potential diagnostic tool for the early screening of cancers. Importantly, the metal-based probes avoid the problems of poor photostability and photobleaching that limit conventional fluorescent imaging dyes.

The research project entitled "Cell imaging of dopamine receptor using agonist labeling iridium(III) complex" was led by Dr. Edmond Ma of HKBU together with Professor Leung Chung-hang of the Institute of Chinese Medical Sciences, University of Macau. Other collaborators of the project included researchers from the School of Chinese Medicine of HKBU, the City University of Hong Kong, University of Florida, USA, and Hunan University, China.

Dr. Ma said, "Early detection is crucial for improving the survival rate of hard-to-treat cancers such as lung cancer, which is associated with dopamine receptor expression. For instance, data from the American Cancer Society shows that patients with early stage non-small cell lung cancer (NSCLC) have a five-year survival rate of about 92%, but this drops to only about 36% when the cancer has progressed to an advanced stage. We therefore believe that these dopamine receptor probes show great promise for the development of molecular diagnostic tools for the early detection of cancer."

Dr. Ma added that because the probes could successfully track the internalisation process of dopamine receptors in , they also represent powerful tools for studying the role of dopamine in the pathogenesis of cancer.

Explore further: Dopamine receptor antagonist antipsychotic Tx can affect BP

More information: Kasipandi Vellaisamy et al. Cell imaging of dopamine receptor using agonist labeling iridium(iii) complex, Chemical Science (2017). DOI: 10.1039/C7SC04798C

Related Stories

Investigators eye new target for treating movement disorders

January 19, 2018

Blocking a nerve-cell receptor in part of the brain that coordinates movement could improve the treatment of Parkinson's disease, dyskinesia and other movement disorders, researchers at Vanderbilt University have reported.

New method maps the dopamine system in Parkinson's patients

February 14, 2018

With the aid of a PET camera, researchers from Karolinska Institutet in Sweden have developed a new method for investigating the dopamine system in the brains of patients suffering from Parkinson's disease. The method measures ...

Recommended for you

New battery gobbles up carbon dioxide

September 21, 2018

A new type of battery developed by researchers at MIT could be made partly from carbon dioxide captured from power plants. Rather than attempting to convert carbon dioxide to specialized chemicals using metal catalysts, which ...

Scientists solve the golden puzzle of calaverite

September 21, 2018

Scientists from Russia and Germany have shed light on the crystalline structure of calaverite, foretelling the existence of a new gold compound previously unknown to chemists. The results of their study were published in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.